Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1983 Oct 29;287(6401):1241–1245. doi: 10.1136/bmj.287.6401.1241

Dose dependent effects of oral progesterone on the oestrogenised postmenopausal endometrium.

G Lane, N C Siddle, T A Ryder, J Pryse-Davies, R J King, M I Whitehead
PMCID: PMC1549751  PMID: 6315123

Abstract

Oral progesterone 100, 200, or 300 mg daily was given for the first 10 days of each calendar month to postmenopausal women also receiving conjugated oestrogens 1.25 mg daily continuously. Endometrial biopsy specimens were taken on the sixth day of the third or subsequent cycle of combined treatment for histological, ultrastructural, and biochemical evaluation. Secretory histological changes were induced within the endometrium in a dose dependent manner, as were progesterone sensitive ultrastructural features such as nucleolar channel systems, giant mitochondria, and subnuclear accumulations of glycogen. Dose response relations were also observed for suppression of DNA synthesis and nuclear oestrogen receptor, and for induction of the activities of oestradiol and isocitric dehydrogenases. Progesterone administered by mouth clearly provokes an end organ response within the endometrium. Suboptimal effects were observed with the lower doses but progesterone 300 mg daily achieved responses approaching and within the physiological range. This dose may therefore be effective as an alternative to synthetic progestogens for therapeutic purposes.

Full text

PDF
1241

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bradley D. D., Wingerd J., Petitti D. B., Krauss R. M., Ramcharan S. Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. N Engl J Med. 1978 Jul 6;299(1):17–20. doi: 10.1056/NEJM197807062990104. [DOI] [PubMed] [Google Scholar]
  2. Gambrell R. D., Jr The prevention of endometrial cancer in postmenopausal women with progestogens. Maturitas. 1978 Sep;1(2):107–112. doi: 10.1016/0378-5122(78)90017-8. [DOI] [PubMed] [Google Scholar]
  3. Gordon M. Cyclic changes in the fine structure of the epithelial cells of human endometrium. Int Rev Cytol. 1975;42:127–172. doi: 10.1016/s0074-7696(08)60980-8. [DOI] [PubMed] [Google Scholar]
  4. Gordon T., Castelli W. P., Hjortland M. C., Kannel W. B., Dawber T. R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977 May;62(5):707–714. doi: 10.1016/0002-9343(77)90874-9. [DOI] [PubMed] [Google Scholar]
  5. Kalkhoff R. K. Metabolic effects of progesterone. Am J Obstet Gynecol. 1982 Mar 15;142(6 Pt 2):735–738. doi: 10.1016/s0002-9378(16)32480-2. [DOI] [PubMed] [Google Scholar]
  6. Kay C. R. James Mackenzie Lecture 1979. The happiness pill? J R Coll Gen Pract. 1980 Jan;30(210):8–19. [PMC free article] [PubMed] [Google Scholar]
  7. King R. J., Townsend P. T., Siddle N., Whitehead M. I., Taylor R. W. Regulation of estrogen and progesterone receptor levels in epithelium and stroma from pre- and postmenopausal endometria. J Steroid Biochem. 1982 Jan;16(1):21–29. doi: 10.1016/0022-4731(82)90139-x. [DOI] [PubMed] [Google Scholar]
  8. King R. J., Townsend P. T., Whitehead M. I. The role of estradiol dehydrogenase in mediating progestin effects on endometrium from postmenopausal women receiving estrogens and progestins. J Steroid Biochem. 1981 Mar;14(3):235–238. doi: 10.1016/0022-4731(81)90130-8. [DOI] [PubMed] [Google Scholar]
  9. King R. J., Townsend P. T., Whitehead M. I., Young O., Taylor R. W. Biochemical analyses of separated epithelium and stroma from endometria of premenopausal and postmenopausal women receiving estrogen and progestins. J Steroid Biochem. 1981 Oct;14(10):979–987. doi: 10.1016/0022-4731(81)90205-3. [DOI] [PubMed] [Google Scholar]
  10. King R. J., Whitehead M. I., Campbell S., Minardi J. Effect of estrogen and progestin treatments on endometria from postmenopausal women. Cancer Res. 1979 Mar;39(3):1094–1101. [PubMed] [Google Scholar]
  11. Larsson-Cohn U., Fåhraeus L., Wallentin L., Zador G. Lipoprotein changes may be minimized by proper composition of a combined oral contraceptive. Fertil Steril. 1981 Feb;35(2):172–179. doi: 10.1016/s0015-0282(16)45318-5. [DOI] [PubMed] [Google Scholar]
  12. Meade T. W., Greenberg G., Thompson S. G. Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations. Br Med J. 1980 May 10;280(6224):1157–1161. doi: 10.1136/bmj.280.6224.1157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ross R. K., Paganini-Hill A., Mack T. M., Arthur M., Henderson B. E. Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet. 1981 Apr 18;1(8225):858–860. doi: 10.1016/s0140-6736(81)92138-3. [DOI] [PubMed] [Google Scholar]
  14. Smith J. A., King R. J., Meggitt B. F., Allen L. N. Biochemical studies on human and rat breast tissues. Br J Cancer. 1966 Jun;20(2):335–344. doi: 10.1038/bjc.1966.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Spellacy W. N., Buhi W. C., Birk S. A. Effects of norethindrone on carbohydrate and lipid metabolism. Obstet Gynecol. 1975 Nov;46(5):560–563. [PubMed] [Google Scholar]
  16. Spellacy W. N., Buhi W. C., Birk S. A. Prospective studies of carbohydrate metabolism in "normal" women using norgestrel for eighteen months. Fertil Steril. 1981 Feb;35(2):167–171. doi: 10.1016/s0015-0282(16)45317-3. [DOI] [PubMed] [Google Scholar]
  17. Whitehead M. I., King R. J., McQueen J., Campbell S. Endometrial histology and biochemistry in climacteric women during oestrogen and oestrogen/progestogen therapy. J R Soc Med. 1979 May;72(5):322–327. doi: 10.1177/014107687907200504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Whitehead M. I., Townsend P. T., Gill D. K., Collins W. P., Campbell S. Absorption and metabolism of oral progesterone. Br Med J. 1980 Mar 22;280(6217):825–827. doi: 10.1136/bmj.280.6217.825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Whitehead M. I., Townsend P. T., Pryse-Davies J., Ryder T. A., King R. J. Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. N Engl J Med. 1981 Dec 31;305(27):1599–1605. doi: 10.1056/NEJM198112313052701. [DOI] [PubMed] [Google Scholar]
  20. Whitehead M. I., Townsend P. T., Pryse-Davies J., Ryder T., Lane G., Siddle N. C., King R. J. Effects of various types and dosages of progestogens on the postmenopausal endometrium. J Reprod Med. 1982 Aug;27(8 Suppl):539–548. [PubMed] [Google Scholar]
  21. Whitehead M. I., Townsend P. T., Pryse-Davies J., Ryder T., Lane G., Siddle N., King R. J. Actions of progestins on the morphology and biochemistry of the endometrium of postmenopausal women receiving low-dose estrogen therapy. Am J Obstet Gynecol. 1982 Mar 15;142(6 Pt 2):791–795. doi: 10.1016/s0002-9378(16)32490-5. [DOI] [PubMed] [Google Scholar]
  22. Yaari S., Goldbourt, Even-Zohar S., Neufeld H. N. Associations of serum high density lipoprotein and total cholesterol with total, cardiovascular, and cancer mortality in a 7-year prospective study of 10 000 men. Lancet. 1981 May 9;1(8228):1011–1015. doi: 10.1016/s0140-6736(81)92184-x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES